GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 128 filers reported holding GOSSAMER BIO INC in Q3 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,588,841 | -58.9% | 309,300 | -57.3% | 0.00% | 0.0% |
| Q1 2022 | $6,291,264 | -23.2% | 724,800 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $8,197,000 | -10.0% | 724,800 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $9,111,000 | +54.8% | 724,800 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $5,885,000 | -12.2% | 724,800 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $6,704,000 | -23.5% | 724,800 | -20.0% | 0.00% | 0.0% |
| Q4 2020 | $8,761,000 | -22.1% | 906,000 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $11,243,000 | -4.5% | 906,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $11,778,000 | +146.9% | 906,000 | +92.8% | 0.00% | +50.0% |
| Q1 2020 | $4,771,000 | -61.6% | 470,000 | -40.8% | 0.00% | -33.3% |
| Q4 2019 | $12,415,000 | -0.5% | 794,275 | +6.9% | 0.00% | -25.0% |
| Q3 2019 | $12,475,000 | -14.4% | 742,991 | +13.1% | 0.00% | -20.0% |
| Q2 2019 | $14,574,000 | +43.1% | 657,081 | +39.8% | 0.01% | +66.7% |
| Q1 2019 | $10,185,000 | – | 470,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |